Drug shortages

Medroxyprogesterone Acetate Tablet

Pfizer Inc.

To Be Discontinued0009-0287-01Urology
Open FDA's page for this record
Discontinued date
11/19/2026
Update type
New
Initial posting date
11/19/2026
Package NDC
0009-0287-01
Generic name
Medroxyprogesterone Acetate Tablet
Contact info
800-533-4535
Related info
Discontinuation of the manufacture of the drug
Update date
11/19/2026
Dosage form
Tablet
Presentation
Provera, Tablet, 5 mg (NDC 0009-0287-01)
Company name
Pfizer Inc.
Status
To Be Discontinued
Therapeutic category
Urology
Harmonized identifiers (openFDA)
Application number
NDA011839
Brand name
PROVERA
Generic name
MEDROXYPROGESTERONE ACETATE
Manufacturer name
Pharmacia & Upjohn Company LLC
Product NDC
0009-0287, 0009-0065, 0009-0051
Product type
HUMAN PRESCRIPTION DRUG
Route
ORAL
Substance name
MEDROXYPROGESTERONE ACETATE
RxCUI
1000114, 1000124, 1000135, 1000139, 1000141, 1000145
SPL ID
ebcdf2fb-760c-4a9a-80a1-a0c6b21a891a
SPL set ID
a586be28-96af-4fed-a13f-9b94fd4c7405
Package NDC
0009-0065-01, 0009-0287-01, 0009-0051-01
UNII
C2QI4IOI2G
Wholesale access for licensed clinicians.

Free to join: your NPI is checked against the federal registry at signup, then wholesale pricing and the professional shelves open.

Data from openFDA, FDA's public API. FDA says not to rely on it to make decisions about medical care and to treat every result as unvalidated; confirm against FDA's own record and the product labeling. Not medical or legal advice.